A novel, effective and painless transdermal drug delivery system (TDDS) would be a blessing to all the patients in the world, microarray patch (MAP) has the great potential to meet that goal; WCC is committed to be a leader on making MAP. Vision Mission Currently, MAP can be applied in four areas, i.e. cosmetic applications, medical device, medicines and vaccines. WCC has been engaged and developed specific products in these four areas.

怡定興科技之願景、使命與價值

成為在微針傳輸系統中創新研發與生產製造的領導者​，提供人類一個全新劑型選擇​，立足台灣，跨足亞洲，前進全球​

​

A novel, effective and painless transdermal drug delivery system (TDDS) would be a blessing to all the patients in the world, microarray patch (MAP) has the great potential to meet that goal; WCC is committed to be a leader on making MAP. Vision Mission Currently, MAP can be applied in four areas, i.e. cosmetic applications, medical device, medicines and vaccines. WCC has been engaged and developed specific products in these four areas.
About Us
Contact Now

WCC BIOMEDICAL

Founded in 2014, WCC Biomedical develops and manufactures microarray patches (MAPs) on its in-house WINMAP™ platform, serving three fields: cosmetic-healthcare, pharmaceuticals and vaccines. In September 2026, the IND for microneedle drug WCC-301, covering a combined Phase I/II clinical trial, came into effect.

CORE TECHNOLOGY

M²DB AND PD²F

WCC pioneered two robust databases for quick material selection and formulation processes, enabling the fabrication of MAPs that meet product requirements.​

Precision Loading & Coating

Precision Loading and Coating is the method that WCC utilizes to consistently produce high-quality MAPs with precise drug loading.

Automatic Mass Production

WCC employs automatic mass production technology, enabling the production of over 10 million MAPs annually with a high yield rate.

Microneedle patch production line overview

Automation
0 %
Yield
0 %
Annual output
0.01 Million pcs

THREE AREAS

Cosmetics-Healthcare

MNP are a breakthrough for the cosmetic and healthcare markets, as they enable functional ingredients to be delivered precisely to targeted areas. This targeted delivery promotes faster absorption and supports quicker recovery.
READ MORE

Therapeutics

MNP has become a powerful platform for drug delivery, a much faster and higher absorption rate can be achieved while comparing with the traditional transdermal patches.
READ MORE

Vaccine

A solid vaccine MNP can be administered to a patient in a painless and convenient way. The dosage is much reduced then a traditional IV approach. The cost of “cold chain” can also be substantially reduced.
READ MORE

news

The Latest

More

Become A Partner

Hsinchu Manufacturing Facility

5F., No. 6, Duxing Rd., East Dist., Hsinchu City 300, Taiwan (R.O.C.)
+886 3 5795276

Taipei Office (Taipei BioInnovation Park)

Rm. B, No.508-5, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115011, Taiwan (R.O.C.)
+886 2 27863988

Contact Us Now